BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma HN, Cao KS, Liu YM, Chen C, Zhang H, Tang FS. Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment. World J Gastroenterol 2025; 31(10): 102580 [PMID: 40093664 DOI: 10.3748/wjg.v31.i10.102580]
URL: https://www.wjgnet.com/1007-9327/full/v31/i10/102580.htm
Number Citing Articles
1
Zhi-Hao Zeng, Jin-Qing Liu, Min Zhang, Cai-Liang Qiu, Zhen-Yu Xu. Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switchWorld Journal of Gastroenterology 2025; 31(26): 109285 doi: 10.3748/wjg.v31.i26.109285